A 52-week randomized controlled trial of ipragliflozin or sitagliptin in type 2 diabetes combined with metformin: The N-ISM study.
Kitazawa M, Katagiri T, Suzuki H, Matsunaga S, H Yamada M, Ikarashi T, Yamamoto M, Furukawa K, Iwanaga M, Hatta M, Fujihara K, Yamada T, Tanaka S, Sone H.
Kitazawa M, et al. Among authors: ikarashi t.
Diabetes Obes Metab. 2021 Mar;23(3):811-821. doi: 10.1111/dom.14288. Epub 2021 Jan 8.
Diabetes Obes Metab. 2021.
PMID: 33416200
Free PMC article.
Clinical Trial.